Yuki Nishiko

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma.

Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma.

Journal: Biochemical and biophysical research communications

Published: July 15, 2026

Natural-killer-cell-dominant immune landscape and HLA-E-mediated immune evasion in choriocarcinoma.

Natural-killer-cell-dominant immune landscape and HLA-E-mediated immune evasion in choriocarcinoma.

Journal: Placenta

Published: August 17, 2025

Downregulation of Chromosome 19 miRNA Cluster and the Tumor-Suppressive Role of miR-517a-3p in Choriocarcinoma.

Downregulation of Chromosome 19 miRNA Cluster and the Tumor-Suppressive Role of miR-517a-3p in Choriocarcinoma.

Journal: Cancer science

Published: April 22, 2025

Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study.

Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study.

Journal: International journal of clinical oncology

Published: February 18, 2025

Utility of manual vacuum aspiration followed by curettage in the treating hydatidiform mole: A retrospective analysis.

Utility of manual vacuum aspiration followed by curettage in the treating hydatidiform mole: A retrospective analysis.

Journal: The journal of obstetrics and gynaecology research

Published: October 04, 2024

Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq.

Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq.

Journal: Gynecologic oncology

Published: June 28, 2024

Corrigendum to "A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab" [Taiwan J Obst Gynecol 62 (5) (2023) 745-748].

Corrigendum to "A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab" [Taiwan J Obst Gynecol 62 (5) (2023) 745-748].

Journal: Taiwanese journal of obstetrics & gynecology

Published: April 01, 2024

A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab.

A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab.

Journal: Taiwanese journal of obstetrics & gynecology

Published: May 10, 2023

Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.

Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.

Journal: BMC cancer

Published: April 27, 2023

Cell surface membrane lysosome-associated membrane glycoprotein 2 promotes cell adhesion via abundant N-glycans in choriocarcinoma.

Cell surface membrane lysosome-associated membrane glycoprotein 2 promotes cell adhesion via abundant N-glycans in choriocarcinoma.

Journal: Placenta

Published: October 08, 2021

Evaluation of the risk of umbilical cord prolapse in the second twin during vaginal delivery: a retrospective cohort study.

Evaluation of the risk of umbilical cord prolapse in the second twin during vaginal delivery: a retrospective cohort study.

Journal: BMJ open

Published: June 17, 2021

The efficacy of therapeutic cervical cerclage in singleton pregnancies: a retrospective study.

The efficacy of therapeutic cervical cerclage in singleton pregnancies: a retrospective study.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: April 12, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026